Kamal, Mohammad

Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment

Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 758

Phytol: A review of biomedical activities

Islam, M. T., Ali, E. S., Uddin, S. J., Shaw, S., Islam, M. A., Ahmed, M. I., Chandra Shill, M., Karmakar, U. K., Yarla, N. S., Khan, I. N., et al. (2018) · Food and Chemical Toxicology

Bioactive Natural Diterpenoids ResearchPhytochemistry and Biological Activities

Cited by 490

Status of Acetylcholinesterase and Butyrylcholinesterase in Alzheimer's Disease and Type 2 Diabetes Mellitus

Mushtaq, G., Greig, N., Khan, J., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets

Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments

Cited by 331

Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus

Ashraf, G., Greig, N., Khan, T., Hassan, I., Tabrez, S., Shakil, S., Sheikh, I., Zaidi, S., Akram, M., Jabir, N., et al. (2014) · CNS & Neurological Disorders - Drug Targets

Alzheimer's disease research and treatmentsPrion Diseases and Protein Misfolding

Cited by 236

Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease

Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry

Mitochondrial Function and PathologyAlzheimer's disease research and treatments

Cited by 138

Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development

Mueed, Z., Tandon, P., Maurya, S. K., Deval, R., Kamal, M. A., & Poddar, N. K. (2019) · Frontiers in Neuroscience

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 111

Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases

Reale, M., Greig, N., & Kamal, M. (2009) · Mini-Reviews in Medicinal Chemistry

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 82

Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer’s Disease- Diabetes Type 2 Linkage via an Enzoinformatics Study

Rizvi, S., Shakil, S., Biswas, D., Shakil, S., Shaikh, S., Bagga, P., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets

Cholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods

Cited by 71

Nanoparticles guided drug delivery and imaging in gastric cancer

Nagaraju, G. P., Srivani, G., Dariya, B., Chalikonda, G., Farran, B., Behera, S. K., Alam, A., & Kamal, M. A. (2021) · Seminars in Cancer Biology

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 62

A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An Update

Alam, M., Alam, Q., Kamal, M., Abuzenadah, A., & Haque, A. (2014) · CNS & Neurological Disorders - Drug Targets

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 47

Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes

Mahboobi, H., Golmirzaei, J., Gan, S., Jalalian, M., & Kamal, M. (2014) · CNS & Neurological Disorders - Drug Targets

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 21

Antifungal Activity of Plant Secondary Metabolites on Candida albicans: An Updated Review

Khan, A., Moni, S. S., Ali, M., Mohan, S., Jan, H., Rasool, S., Kamal, M. A., Alshahrani, S., Halawi, M., & Alhazmi, H. A. (2023) · Current Molecular Pharmacology

Antifungal resistance and susceptibilityEssential Oils and Antimicrobial Activity

Cited by 17